Acasti Pharma Inc.
NASDAQ:ACST
3.37 (USD) • At close October 25, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities: | ||||||||||||||
| Net Income
| -12.853 | -42.429 | -9.819 | -19.678 | -25.513 | -38.62 | -16.652 | -4.661 | -1.323 | -10.436 | -6.732 | -6.539 | -2.427 | -1.508 |
| Depreciation & Amortization
| 0.011 | 0.124 | 0 | 0.924 | 2.32 | 2.117 | 2.069 | 1.767 | 1.866 | 1.594 | 0.65 | 0.672 | 0.013 | 0.009 |
| Deferred Income Tax
| -1.832 | -9.542 | -0.648 | 8.943 | 1.362 | 0.435 | -0.005 | 0.277 | 0.001 | -0.084 | 0.012 | -0.013 | 0 | 0 |
| Stock Based Compensation
| 0.913 | 1.811 | 1.337 | 1.174 | 1.953 | 0.78 | 0.719 | 0.228 | 1.242 | 3.093 | 1.873 | 1.328 | 0.108 | 0 |
| Change In Working Capital
| -1.28 | 0.181 | -2.786 | -5.946 | -3.211 | 6.059 | 2.774 | -0.031 | 1.044 | -1.013 | 1.793 | -1.084 | 0.401 | -0.402 |
| Accounts Receivables
| 0.08 | -0 | -0.018 | 0.058 | 0.581 | -0.62 | -0.428 | 0.035 | 0.427 | -0.421 | -0.008 | 0 | 0 | 0 |
| Inventory
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.064 | 0.139 | -0.035 | 0.369 | -0.603 | 0 | 0 |
| Accounts Payables
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.037 | -0.07 | 0.417 | -0.282 | 0 | 0 | 0 |
| Other Working Capital
| -1.36 | 0.181 | -2.768 | -6.004 | -3.792 | 6.679 | 3.203 | -0.167 | 0.547 | -0.974 | 1.715 | -0.481 | 0 | 0 |
| Other Non Cash Items
| 1.731 | 33.942 | -5.318 | 0.264 | 0.145 | 4.906 | 1.4 | -2.431 | -8.584 | 0.73 | -0.085 | -0.012 | -0 | 0 |
| Operating Cash Flow
| -12.333 | -15.913 | -17.234 | -14.319 | -22.944 | -24.323 | -9.694 | -4.852 | -5.753 | -6.116 | -2.49 | -5.648 | -1.904 | -1.902 |
| Investing Activities: | ||||||||||||||
| Investments In Property Plant And Equipment
| -0.022 | -0.017 | 0 | -0.069 | -0.319 | -0.524 | -0.352 | -0.271 | -0.069 | -0.134 | -0.101 | 0 | -0.022 | -0.015 |
| Acquisitions Net
| 0.111 | 5.032 | 0 | 9.879 | 2.242 | 0 | 0 | -0.068 | -0.041 | -0.111 | 0 | 0 | 0 | 0 |
| Purchases Of Investments
| -6.554 | -5.015 | -34.929 | -9.81 | -1.923 | -17.79 | -0.02 | -8.821 | -11.572 | -22.824 | 0 | -7.544 | -2.564 | 0 |
| Sales Maturities Of Investments
| 6.569 | 18.185 | 31.407 | 0.021 | 10.38 | 8.937 | 0 | 15.081 | 17.703 | 5.392 | 1.954 | 4.526 | 0 | 1.92 |
| Other Investing Activites
| 0.089 | -5.032 | -0.004 | -9.879 | -2.242 | 0.288 | 0.054 | 0.151 | 0.074 | 0.199 | 0.002 | 0.008 | 0 | 0 |
| Investing Cash Flow
| 0.104 | 13.153 | -3.522 | -9.858 | 8.138 | -9.089 | -0.318 | 6.072 | 6.096 | -17.477 | 1.855 | -3.009 | -2.586 | 1.905 |
| Financing Activities: | ||||||||||||||
| Debt Repayment
| 0 | 0 | 0 | 0 | -1.556 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Common Stock Issued
| 7.359 | 0.304 | 0 | 59.332 | 6.981 | 43.358 | 8.568 | 0 | 0 | 21.589 | 0 | 9.886 | 4.397 | 0.077 |
| Common Stock Repurchased
| 0 | 0 | 0 | 0 | 0 | 0 | -0.031 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities
| 7.359 | 0.411 | 0 | 0.158 | 7.751 | 0.726 | 0.295 | -0.002 | 0.037 | 0.847 | 0.222 | 0.056 | 0 | 0 |
| Financing Cash Flow
| 7.359 | 0.304 | 0 | 59.49 | 13.176 | 44.085 | 8.832 | -0.002 | 0.037 | 22.435 | 0.222 | 9.941 | 4.397 | 0.077 |
| Other Information: | ||||||||||||||
| Effect Of Forex Changes On Cash
| 0 | -0.008 | 0.153 | 1.389 | -1.001 | 0.036 | -0.019 | 0.048 | 0.128 | 0.689 | 0.029 | -0.01 | 0 | 0 |
| Net Change In Cash
| -4.87 | -2.464 | -20.603 | 36.702 | -2.631 | 10.709 | -1.199 | 1.267 | 0.508 | -0.468 | -0.384 | 1.275 | -0.093 | 0.08 |
| Cash At End Of Period
| 23.005 | 27.875 | 30.339 | 50.942 | 14.24 | 16.867 | 6.367 | 2.234 | 1.047 | 0.607 | 1.169 | 1.599 | 0.329 | 0.393 |